Hypertensive Encwphalopathy 1
Hypertensive Encwphalopathy 1
Hypertensive Encwphalopathy 1
SESSION
DR.MD.SAZZAD HOSSAIN SAJAL
INTERN DOCTOR
MEDICINE
DEPARTMENT TMMC&H
Hypertensive encephalopathy
and
Hypertensive Emergencies
HYPERTENSIVE
ENCEPHALOPATHY
• Definition:-
• Hypertensive encephalopathy is a rare
condition characterized by high BP and
neurological symptoms, including transient
disturbances of speech or vision,
paraesthesiae, disorientation, fits ,loss of
consciousness and papilloedema.
• Hypertensive encephalopathy is a
neurological dysfunction induced by
malignant hypertension.
• Malignant hypertension is commonly defined
as sustained, elevated arterial blood
pressure, with diastolic levels of 130 mm Hg
or greater and systolic pressure in excess of
200 mm Hg.
(cecil)
Historical note and terminology
The term “hypertensive encephalopathy” was
introduced by Oppenheimer and Fishberg
(Oppenheimer and Fishberg 1928). They
described essential clinical characteristics of
acute malignant hypertension. Ten years
prior, Volhard was the first to separate clearly
acute hypertension-induced neurologic
dysfunction from a uremic state and
introduced the term “pseudouremia” to refer
to hypertensive encephalopathy (Volhard
1918).
PATHOGENESIS:-
• Hypertensive Emergency
– Failure of normal autoregulatory function
– Leads to a sharp increase in systemic vascular
resistance
– Endovascular injury with arteriole necrosis
– Ischemia, platelet deposition and release of
vasoactive substances
– Further loss of autoregulatory mechanism
– Exposes organs to increased pressure
Clinical feature
• hypertensive emergency is a critically ill patient
who presents with a blood pressure above 220/140
mm Hg,
• headaches,
• confusion,
• blurred vision,
• nausea and vomiting,
• seizures,
• pulmonary
edema,
• oliguria
and
• grade 3 or
grade 4
hypertensi
Diagnosis and Recognition
• Presentation
– Always present with a new onset symptom
• Take a good history
– History of HTN and previous control
– Medications with dosage and compliance
– Illicit drug use, OTC drugs
Diagnosis and Recognition
• Physical
– Confirm BP in more than one extremity
– Ensure appropriate cuff size
– Pulses in all extremities
– Lungs examination—look for pulmonary edema
– Cardiac—murmurs or gallops, angina, EKG
– Renal—renal artery bruit, hematuria
– Neurologic—focal deficits, HA, altered MS
– Fundoscopic exam—retinopathy, hemorrhage
Diagnosis and Recognition
• Laboratory/Radiologic evaluations
– BUN
– CBC with smear (hemolytic anemia)
– Urine (proteinuria, hematuria)
– S. creatinin
– ECG to look for ischemia
– CXR to look for pulmonary edema if dyspnea
– Head CT for evaluation of stroke
– MRI chest if unequal pulses and wide
mediastinum to look for aortic dissection
Treatmen
• t
Hypertensive Emergency
– Goal: Lower DBP by 10-15% in 30-60 min
– controlled reduction to a level of about 150/90 mmHg
over a period of 24–48 hours is ideal
– Initiate oral therapy and IV medications down
• Intravenous or intramuscular labetalol (2 mg/min to a
maximum of 200 mg),
• intravenous glyceryl trinitrate (0.6–1.2 mg/hr),
• intramuscular hydralazine (5 or 10 mg aliquots repeated
at half hourly intervals)
• intravenous sodium nitroprusside (0.3–1.0 µg/kg body
weight/min)
Medications
• Preferred agents by end organ damage
– Pulmonary Edema (systolic)—Nicardipine
– Pulmonary Edema (diastolic)—Esmolol
– Myocardial ischemia and infarction
Nicardipine plus esmolol
Nitroglycerin plus
labetalol Nitroglycerin
plus esmolol
– Hypertensive Encephalopathy—
Labetolol
– Acute Aortic Dissection—Labetolol
– Eclampsia—Labetolol or Nicardipine
– Acute kidney injury
Fenoldopam
Nicardipine
– Sympathetic Crisis/Cocaine—Verapamil
or Diltiazem
References
• Davidson’s principles and practice of
medicine
• Kumar & Clark's Clinical Medicine, 7th Edition
• Goldman's Cecil Medicine, 24th
• CURRENT Medical Diagnosis and Treatment
2015
• www.wekipidea.com
• Flanigan, J. and Vitberg, D. “Hypertensive Emergency
and Severe Hypertension: What to Treat, Who to Treat,
and How to Treat.” The Medical Clinics of
North America. Vol 90 (2006) pp. 439-451.